Epilepsy trials recruiting in Tennessee

All Epilepsy trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
  NCT07019922 · Phase: Phase 3 · Ages: 1 Day to 18 Years · Sex: All (male and female) · Tennessee: Memphis
• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
  NCT06872125 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Tennessee: Memphis
• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
  NCT07219407 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Tennessee: Nashville
• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
  NCT06660394 · Phase: Phase 3 · Ages: 2 Years to 65 Years · Sex: All (male and female) · Tennessee: Memphis
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
  NCT05716100 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Nashville
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
  NCT04462770 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Tennessee: Memphis
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Tennessee: Nashville
• ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
  NCT07531745 · Phase: Phase 1, Phase 2 · Ages: 2 Years to 12 Years · Sex: All (male and female) · Tennessee: Memphis
• Effect of Rose Odor Exposure on Ictal Apnea
  NCT07116421 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Nashville
• Physiological Brain Atlas Development
  NCT00575081 · Phase: Not specified · Ages: 6 Years to 90 Years · Sex: All (male and female) · Tennessee: Nashville
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
  NCT07594119 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Tennessee: Nashville
• Subcortical Arousal in Perceptual Awareness
  NCT06934356 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years and older · Sex: All (male and female) · Tennessee: Nashville